Subscribe Now Subscribe Today
Editorial
 

It is Time to Formulate an Antioxidant Mixture for Management of Diabetes and its Complications: Notice for Pharmaceutical Industries



Asieh Hosseini and Mohammad Abdollahi
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
ABSTRACT

Not Available

Services
Related Articles in ASCI
Search in Google Scholar
View Citation
Report Citation

 
  How to cite this article:

Asieh Hosseini and Mohammad Abdollahi, 2012. It is Time to Formulate an Antioxidant Mixture for Management of Diabetes and its Complications: Notice for Pharmaceutical Industries. International Journal of Pharmacology, 8: 60-61.

DOI: 10.3923/ijp.2012.60.61

URL: https://scialert.net/abstract/?doi=ijp.2012.60.61
 
Received: October 16, 2011; Accepted: December 18, 2011; Published: February 20, 2012



Diabetes is a prevalent disease affecting a considerable proportion of the population worldwide. The number of people with diabetes is increasing dramatically that is finally associated with major health and socio-economic problems. To manage diabetes, new chemical drugs are still introduced but their efficacy or safety is still a concern (Salari et al., 2011).

Oxidative stress is the result of an imbalance between production of reactive oxygen species from sources inside or outside the body and the biological system’s ability to detoxify the reactive intermediates or repair the resulting damage (Abdollahi et al., 2004). In insulin dependent and independent diabetes, oxidative stress is involved by generation of oxygen free radicals due to nonenzymatic protein glycosylation, auto-oxidation of glucose and also by changing the level of antioxidant defense enzyme. Therefore, increased production of free radicals and oxidative stress is a central player in development of diabetes complication (Rahimi et al., 2005). If the relationship between oxidative stress and diabetes is considered in depth, there would be no doubt that use of antioxidants from natural sources should be helpful and safe (Hasani-Ranjbar et al., 2009; Ranjbar et al., 2011).

In the recent years, some herbals sources have been examined in animal models of diabetes or human that indicated very positive effects. Among these natural sources that were examined, some showed promising effects that cannot be ignored. These include species of Satureja (Momtaz and Abdollahi, 2010; Vosough-Ghanbari et al., 2010), Urtica (Mehri et al., 2011), Teucrium (Hasani-Ranjbar et al., 2010), Angipars (Hemmatabadi et al., 2009), IMOD (Mohammadirad et al., 2011) and nanoparticles of cerium (Pourkhalili et al., 2011). Fortunately most of these natural antioxidants have passed safety tests and even trialed in human. If the costs of pharmacotherapy of diabetes and its complications are carefully considered and calculated in human, the socioeconomic burden would be clarified. Therefore, it is the time for pharmaceutical industries to follow up these reports and try to expand studies about above-mentioned compounds to finally formulate a useful mixture for diabetes.

REFERENCES

1:  Abdollahi, M., A. Ranjbar, S. Shadnia, S. Nikfar and A. Rezaie, 2004. Pesticides and oxidative stress: A review. Med. Sci. Monit., 10: RA141-RA147.
PubMed  |  Direct Link  |  

2:  Hasani-Ranjbar, S., B. Larijani and M. Abdollahi, 2009. A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm. Allergy Drug Targets, 8: 2-10.
PubMed  |  Direct Link  |  

3:  Hasani-Ranjbar, S., B. Larijani and M. Abdollahi, 2011. Recent update on animal and human evidences of promising antidiabetic medicinal plants: A mini-review of targeting new drugs. Asian J. Anim. Vet. Adv., 6: 1271-1275.
CrossRef  |  Direct Link  |  

4:  Hasani-Ranjbar, S., N. Nayebi, B. Larijani and M. Abdollahi, 2010. A systematic review of the efficacy and safety of Teucrium species; from anti-oxidant to anti-diabetic effects. Int. J. Pharmacol., 6: 315-325.
CrossRef  |  Direct Link  |  

5:  Hemmatabadi, M., M. Abdollahi, S. Bakhshayeshi, R. Heshmat, M. Baeeri, O. Azimaraghi and B. Larijani, 2009. Benefits of Semelil (ANGIPARSTM) on oxidant-antioxidant balance in diabetic patients: A randomized, double-blind placebo controlled clinical trial. DARU J. Pharm. Sci., 17: 50-55.
Direct Link  |  

6:  Mohammadirad, A., H.R. Khorram-Khorshid, F. Gharibdoost and M. Abdollahi, 2011. Setarud (IMODTM) as a multiherbal drug with promising benefits in animal and human studies: A comprehensive review of biochemical and cellular evidences. Asian J. Anim. Vet. Adv., 6: 1185-1192.
CrossRef  |  Direct Link  |  

7:  Momtaz, S. and M. Abdollahi, 2010. An update on pharmacology of Satureja species; From antioxidant, antimicrobial, antidiabetes and anti-hyperlipidemic to reproductive stimulation. Int. J. Pharmacol., 6: 346-353.
CrossRef  |  Direct Link  |  

8:  Pourkhalili, N., A. Hosseini, A. Nili-Ahmadabadi, S. Hassani and M. Pakzad et al., 2011. Biochemical and cellular evidence of the benefit of a combination of cerium oxide nanoparticles and selenium to diabetic rats. World J. Diabetes, 2: 204-210.
PubMed  |  Direct Link  |  

9:  Rahimi, R., S. Nikfar, B. Larijani and M. Abdollahi, 2005. A review on the role of antioxidants in the management of diabetes and its complications. Biomed. Pharmacother., 59: 365-373.
PubMed  |  Direct Link  |  

10:  Salari, P., S. Nikfar and M. Abdollahi, 2011. No superiority of exenatide over insulin in diabetic patients in terms of weight reduction or incidence of adverse effects: A meta-analysis. Int. J. Pharmacol., 7: 749-756.
CrossRef  |  Direct Link  |  

11:  Mehri, A., S. Hasani-Ranjbar, B. Larijani and M. Abdollahi, 2011. A systematic review of efficacy and safety of Urtica dioica in the treatment of diabetes. Int. J. Pharmacol., 7: 161-170.
CrossRef  |  Direct Link  |  

12:  Vosough-Ghanbari, S., R. Rahimi, S. Kharabaf, S. Zeinali and A. Mohammadirad et al., 2010. Effects of Satureja khuzestanica on serum glucose, lipids and markers of oxidative stress in patients with type 2 diabetes mellitus: A double-blind randomized controlled trial. Evid. Based Complement. Alternat. Med., 7: 465-470.
CrossRef  |  PubMed  |  Direct Link  |  

©  2022 Science Alert. All Rights Reserved